Author:
Hijazi Ziad,Wallentin Lars,Siegbahn Agneta,Andersson Ulrika,Alexander John H.,Atar Dan,Gersh Bernard J.,Hanna Michael,Harjola Veli Pekka,Horowitz John D.,Husted Steen,Hylek Elaine M.,Lopes Renato D.,McMurray John J.V.,Granger Christopher B.
Funder
Boehringer Ingelheim
AstraZeneca, Merck & Co., Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, and GlaxoSmithKline
AstraZeneca, Boehringer Ingelheim, and Bristol-Myers Squibb;
AstraZeneca and Boehringer Ingelheim
Bristol-Myers Squibb/Pfizer, CSL Behring, Merck/Schering-Plough, and Regado Biosciences
GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Bayer, Boehringer Ingelheim, and Sanofi-Aventis
Bristol-Myers Squibb, AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo
Bristol-Myers Squibb/Pfizer
Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic Foundation, Merck & Co., Pfizer, Sanofi-Aventis, Takeda, and The Medicines Company
Subject
Cardiology and Cardiovascular Medicine